To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STK17BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
274 supporting clones for gene STK17B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK312865 trachea .a 1 to 1440 2 to 1441 exact tiling clone,   1441/1441
(100 %)
4 diff
(99.8 %id)
DB222038 trachea .a 1 to 557 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
TI_1948085631   .a 321 to 874 133 to 686       554/1331
(41 %)
26 diff
(98.1 %id)
TI_1948085782   .a 321 to 981 120 to 785       666/1361
(48 %)
35 diff
(97.5 %id)
TI_1948085936   .a 321 to 985 116 to 783       667/1412
(47 %)
19 diff
(98.7 %id)
TI_1948086096   .a 321 to 985 133 to 796       664/1398
(47 %)
14 diff
(99.0 %id)
CR542210   .a 322 to 1440 1 to 1119 R281G tiling clone,   1119/1119
(100 %)
2 diff
(99.9 %id)
CR542225   .a 322 to 1437 1 to 1116   tiling clone,   1116/1116
(100 %)
2 diff
(99.9 %id)
CV028629 mixed .a 322 to 844 1 to 523       523/523
(100 %)
5 diff
(99.1 %id)
DA475257   .a 342 to 902 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
BE696022 colon .a 361 to 917 558 to 3   tiling clone,   556/558
(99 %)
2 diff
(99.7 %id)
AW504646 lymph .a 383 to 854 1 to 472       472/472
(100 %)
7 diff
(98.6 %id)
TI_154160927   .a 390 to 1120 75 to 799       725/726
(99 %)
16 diff
(97.8 %id)
CB141122 Liver .a 412 to 1076 1 to 665       665/665
(100 %)
3 diff
(99.6 %id)
BF573528 melanotic melanoma, high MDR, skin .a 464 to 1118 1 to 651       651/651
(100 %)
12 diff
(98.2 %id)
CD522530 pooled .a 559 to 1192 1 to 642       640/812
(78 %)
18 diff
(97.8 %id)
AW014705   .a 640 to 785 1 to 146     Submitted on the opposite strand 146/150
(97 %)
7 diff
(95.4 %id)
AW501168 lymph .a 657 to 1061 14 to 418       404/420
(96 %)
7 diff
(98.4 %id)
CF144085 lymph .a 657 to 1033 14 to 390       376/390
(96 %)
6 diff
(98.5 %id)
TI_154155809   .a 657 to 1082 87 to 512       426/433
(98 %)
2 diff
(99.6 %id)
TI_154175939   .a 657 to 1052 83 to 478       396/403
(98 %)
1 diff
(99.8 %id)
BM752511 Ascites, stomach .a 766 to 1288 1 to 523       523/523
(100 %)
3 diff
(99.5 %id)
AW501251 lymph .a 1042 to 1296 1 to 255       255/255
(100 %)
5 diff
(98.1 %id)
AW501254 lymph .a 1042 to 1339 1 to 299       299/299
(100 %)
9 diff
(97.0 %id)
TI_57176918   .b 1 to 727 57 to 790       738/795
(92 %)
27 diff
(96.7 %id)
DA720273   .b 1 to 576 2 to 580   tiling clone, capped   579/582
(99 %)
6 diff
(99.0 %id)
DB447918.
matches multiple genes
testis .b 7 to 400 1 to 394     also hits gene fercharbu 394/394
(100 %)
2 diff
(99.5 %id)
BP288906 lung .b 7 to 589 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
NM_004226.3   .b 7 to 5312 1 to 5306 exact RefSeq, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 5306/5306
(100 %)
0 diff
(100 %id)
BI831240 brain, medulla .b 10 to 727 1 to 725       725/730
(99 %)
21 diff
(97.2 %id)
BP369286 testis .b 22 to 601 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB030992 testis .b 23 to 535 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
TI_57175658   .b 27 to 665 93 to 738       646/870
(74 %)
33 diff
(96.3 %id)
BI831854 brain, medulla .b 33 to 665 1 to 640       640/772
(82 %)
26 diff
(96.7 %id)
DA472449   .b 35 to 587 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DB147997 thymus .b 35 to 501 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
DA103518 cerebellum .b 37 to 579 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
DA028971   .b 40 to 609 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB479818 hippocampus .b 40 to 542 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DA439050 tongue, tumor tissue .b 41 to 612 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA500670 brain .b 41 to 611 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DA580729   .b 41 to 582 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
BP270458 small intestine .b 41 to 623 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA817747   .b 41 to 594 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB086287 testis .b 41 to 601 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB208078 trachea .b 41 to 555 2 to 516   capped   515/515
(100 %)
2 diff
(99.7 %id)
DB221363 trachea .b 41 to 576 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
DA940854 Spleen .b 42 to 624 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
CR594594 B cells (Ramos cell line) Cot 25-normalized .b 44 to 1952 1 to 1909 exact tiling clone,   1909/1909
(100 %)
0 diff
(100 %id)
AL561359 B cells from Burkitt lymphoma .b 44 to 994 1 to 952       952/1049
(90 %)
13 diff
(98.8 %id)
BX356988 Placenta Cot 25-normalized .b 45 to 967 1 to 923       923/923
(100 %)
7 diff
(99.3 %id)
TI_57151505   .b 47 to 661 22 to 643       622/1046
(59 %)
25 diff
(97.7 %id)
DA457251 tongue, tumor tissue .b 50 to 611 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
CN282892 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 52 to 665 1 to 614       614/618
(99 %)
3 diff
(99.6 %id)
BF979494 testis .b 53 to 772 1 to 726       726/969
(74 %)
39 diff
(96.0 %id)
BI762282 pooled colon, kidney, stomach .b 53 to 661 1 to 616       616/1019
(60 %)
22 diff
(97.9 %id)
BI838707 pooled pancreas and spleen .b 53 to 811 24 to 780       757/806
(93 %)
24 diff
(97.1 %id)
TI_57162138   .b 53 to 811 24 to 780       757/806
(93 %)
24 diff
(97.1 %id)
DN996775 breast cancer, Mammary gland (cancer tissue) .b 59 to 848 1 to 790       790/790
(100 %)
7 diff
(99.2 %id)
BP361078 thalamus .b 63 to 658 1 to 597       597/598
(99 %)
11 diff
(98.2 %id)
DB452960 testis .b 64 to 559 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BG340497 B-cells, primary B-cells from tonsils (cell line) .b 67 to 731 1 to 662       662/663
(99 %)
10 diff
(98.5 %id)
BC016040 Primary B-Cells from Tonsils .b 68 to 1756 1 to 1689 exact available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1689/1689
(100 %)
3 diff
(99.9 %id)
AB011421   .b 70 to 1693 1 to 1624 exact     1624/1627
(99 %)
2 diff
(99.9 %id)
CR607515 Neuroblastoma Cot 50-normalized .b 73 to 1678 1 to 1606 exact     1606/1606
(100 %)
0 diff
(100 %id)
AL529141 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 73 to 919 1 to 847   fully sequenced,   847/847
(100 %)
3 diff
(99.7 %id)
BG024356 lymph, lymphoma, cell line .b 80 to 808 1 to 741       741/1010
(73 %)
41 diff
(96.0 %id)
CR746240 pooled germ cell tumors .b 153 to 325 1 to 173       173/173
(100 %)
0 diff
(100 %id)
CR976583 T-Lymphocytes .b 153 to 885 1 to 734       734/737
(99 %)
5 diff
(99.4 %id)
DB459066 testis .b 207 to 684 1 to 478       478/478
(100 %)
1 diff
(99.8 %id)
AA172300   .b 470 to 810 1 to 342       342/348
(98 %)
3 diff
(99.2 %id)
BF980112 testis .b 882 to 1703 829 to 1       829/903
(91 %)
20 diff
(97.8 %id)
AL529140 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 889 to 1678 793 to 1   fully sequenced,   793/793
(100 %)
11 diff
(98.7 %id)
AV712458   .b 891 to 1650 1 to 758       758/758
(100 %)
4 diff
(99.5 %id)
AL582595 B cells from Burkitt lymphoma .b 948 to 1952 999 to 1       999/1005
(99 %)
10 diff
(99.1 %id)
CA308334 Alveolar Macrophage, lung .b 977 to 1728 766 to 16   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 751/751
(100 %)
3 diff
(99.7 %id)
AI191941   .b 987 to 1685 714 to 17   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 698/698
(100 %)
9 diff
(98.8 %id)
AI652307 pooled germ cell tumors .b 988 to 1583 596 to 1       596/611
(97 %)
26 diff
(95.8 %id)
BE502364 pooled germ cell tumors .b 1039 to 1685 670 to 24   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 647/647
(100 %)
6 diff
(99.1 %id)
BX114957 germinal center B cell .b 1044 to 1763 1 to 720       720/720
(100 %)
3 diff
(99.6 %id)
AA419612 germinal center B cell .b 1044 to 1477 1 to 434       434/436
(99 %)
3 diff
(99.4 %id)
AW002978 pooled germ cell tumors .b 1051 to 1763 724 to 12       713/724
(98 %)
2 diff
(99.8 %id)
TI_154155976   .b 1058 to 1503 98 to 544       447/448
(99 %)
24 diff
(94.7 %id)
AI638874 pooled germ cell tumors .b 1063 to 1685 623 to 1       623/623
(100 %)
2 diff
(99.7 %id)
TI_154115922   .b 1090 to 1753 748 to 87   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 662/792
(83 %)
5 diff
(99.4 %id)
CR593001 Placenta Cot 25-normalized .b 1120 to 1763 1 to 644       644/644
(100 %)
0 diff
(100 %id)
AL551557 placenta, Placenta Cot 25-normalized .b 1120 to 1753 1 to 634   fully sequenced, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 634/634
(100 %)
0 diff
(100 %id)
CA449555 Chondrosarcoma, Left Pelvis .b 1129 to 1753 642 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 624/624
(100 %)
1 diff
(99.9 %id)
AL551520 placenta, Placenta Cot 25-normalized .b 1136 to 1719 587 to 5   fully sequenced, Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 583/587
(99 %)
0 diff
(100 %id)
BP326036 prostata .b 1144 to 1720 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
DA099308 cerebellum .b 1151 to 1704 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BG183084   .b 1164 to 1685 1 to 521   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 521/521
(100 %)
3 diff
(99.5 %id)
BG183085   .b 1164 to 1768 1 to 601       601/625
(96 %)
19 diff
(97.0 %id)
BG183625   .b 1164 to 1670 1 to 506   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 506/506
(100 %)
6 diff
(98.9 %id)
BG190508   .b 1164 to 1723 1 to 559   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 559/559
(100 %)
5 diff
(99.2 %id)
CF137917 lymph .b 1167 to 1575 9 to 417       409/417
(98 %)
6 diff
(98.6 %id)
TI_154167648   .b 1167 to 1647 81 to 561       481/482
(99 %)
0 diff
(100 %id)
BG215948   .b 1180 to 1763 54 to 635       582/846
(68 %)
23 diff
(97.3 %id)
AA725600   .b 1186 to 1686 505 to 5       501/505
(99 %)
0 diff
(100 %id)
TI_154076898   .b 1197 to 1659 579 to 117       463/580
(79 %)
0 diff
(100 %id)
BE929804 placenta_normal .b 1200 to 1634 442 to 13       430/442
(97 %)
0 diff
(100 %id)
AW663678 pooled .b 1210 to 1755 543 to 1       543/543
(100 %)
5 diff
(99.1 %id)
AW771264 Kidney .b 1234 to 1680 449 to 1       449/449
(100 %)
10 diff
(97.8 %id)
CA314147 Human Lung Epithelial cells, lung .b 1236 to 1756 536 to 16   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 521/530
(98 %)
0 diff
(100 %id)
AA973829 pooled germ cell tumors .b 1244 to 1685 442 to 1       442/442
(100 %)
0 diff
(100 %id)
DB548550 hippocampus .b 1267 to 1728 1 to 462     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
DB524555 testis .b 1277 to 1756 1 to 480     Submitted on the opposite strand 480/480
(100 %)
0 diff
(100 %id)
AI656697 pooled germ cell tumors .b 1282 to 1685 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
AI089400 uterus .b 1294 to 1756 473 to 11   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 463/463
(100 %)
0 diff
(100 %id)
DB518426 testis .b 1310 to 1754 1 to 445     Submitted on the opposite strand 445/447
(99 %)
1 diff
(99.8 %id)
AA837270 germinal center B cell .b 1325 to 1681 364 to 9       356/364
(97 %)
0 diff
(100 %id)
AI439542 B-cell, chronic lymphotic leukemia .b 1337 to 1758 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
AW172382 pooled .b 1347 to 1686 340 to 1       340/340
(100 %)
0 diff
(100 %id)
CF140799 CNCAP(3)T-225 cell line, Prostate .b 1353 to 1785 1 to 433       433/433
(100 %)
5 diff
(98.9 %id)
AA171984   .b 1359 to 1729 374 to 1       374/379
(98 %)
3 diff
(99.3 %id)
TI_154171393   .b 1360 to 2160 80 to 880       801/905
(88 %)
58 diff
(93.6 %id)
AI301262 carcinoid, lung .b 1363 to 1752 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
AW505423 lymph .b 1397 to 1853 8 to 464       457/464
(98 %)
2 diff
(99.6 %id)
TI_154161987   .b 1397 to 2096 82 to 777       696/729
(95 %)
33 diff
(95.5 %id)
DA103860 cerebellum .b 1407 to 1950 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
AI497838 pooled .b 1435 to 1754 319 to 1       319/319
(100 %)
1 diff
(99.7 %id)
AW977999   .b 1470 to 1986 517 to 1     Submitted on the opposite strand 517/517
(100 %)
8 diff
(98.5 %id)
AI864312 pooled .b 1505 to 1756 263 to 12   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 252/252
(100 %)
0 diff
(100 %id)
DA675467   .b 1547 to 2136 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
AW104940 pooled .b 1567 to 1984 422 to 4       419/422
(99 %)
0 diff
(100 %id)
AA805077 germinal center B cell .b 1587 to 1987 414 to 14   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
AA832365 germinal center B cell .b 1637 to 1987 364 to 14   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
AW504293 lymph .b 1663 to 2079 8 to 424       417/424
(98 %)
1 diff
(99.8 %id)
TI_154160452   .b 1663 to 2207 86 to 629       544/545
(99 %)
13 diff
(97.7 %id)
DB203806 trachea .b 1712 to 2294 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
CF137344 lymph .b 1890 to 2340 1 to 451       451/451
(100 %)
4 diff
(99.2 %id)
TI_154166785   .b 1896 to 2360 79 to 543       465/465
(100 %)
1 diff
(99.8 %id)
BM450684 eye, retinoblastoma .b 1937 to 2882 1 to 953   tiling clone,   953/994
(95 %)
19 diff
(98.1 %id)
DB143096 thymus .b 1985 to 2550 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
CF138199 lymph .b 2004 to 2481 7 to 484       478/484
(98 %)
0 diff
(100 %id)
TI_154168006   .b 2004 to 2501 80 to 577       498/498
(100 %)
0 diff
(100 %id)
BG119963 adenocarcinoma, cell line, Liver .b 2178 to 2893 1 to 710       710/790
(89 %)
16 diff
(98.0 %id)
BF326051 amnion_normal .b 2182 to 2737 552 to 1       552/554
(99 %)
10 diff
(98.2 %id)
BQ015364 Chondrosarcoma, Left Pubic Bone .b 2206 to 2783 13 to 590     Submitted on the opposite strand 578/598
(96 %)
2 diff
(99.7 %id)
AA393395   .b 2254 to 2456 1 to 203   fully sequenced,   203/203
(100 %)
7 diff
(96.6 %id)
R09730 liver and spleen .b 2271 to 2584 1 to 331   fully sequenced,   331/331
(100 %)
16 diff
(95.2 %id)
AA203487 liver and spleen .b 2271 to 2841 1 to 568       568/863
(65 %)
18 diff
(98.0 %id)
AA279044 germinal center B cell .b 2287 to 2668 1 to 382       382/382
(100 %)
2 diff
(99.5 %id)
AA398733   .b 2426 to 2885 460 to 1   fully sequenced,   460/460
(100 %)
3 diff
(99.4 %id)
AI478841 pooled .b 2430 to 2879 470 to 21   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 450/450
(100 %)
3 diff
(99.4 %id)
AA669004 germinal center B cell .b 2439 to 2876 452 to 15   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 438/438
(100 %)
1 diff
(99.8 %id)
AW859084 colon .b 2444 to 2842 414 to 16       399/414
(96 %)
0 diff
(100 %id)
AW859079 colon .b 2445 to 2832 392 to 5       388/393
(98 %)
0 diff
(100 %id)
AW859063 colon .b 2454 to 2745 8 to 301       294/301
(97 %)
6 diff
(98.1 %id)
AA419485 germinal center B cell .b 2454 to 2879 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AA354624   .b 2505 to 2825 1 to 322   tiling clone,   322/322
(100 %)
2 diff
(99.4 %id)
AW953379   .b 2506 to 3015 1 to 511       511/522
(97 %)
28 diff
(94.7 %id)
T25084   .b 2533 to 2676 1 to 144       144/144
(100 %)
0 diff
(100 %id)
AA748388 germinal center B cell .b 2542 to 2881 347 to 8       340/347
(97 %)
0 diff
(100 %id)
R09731 liver and spleen .b 2554 to 2874 323 to 1   fully sequenced,   323/323
(100 %)
1 diff
(99.7 %id)
AW082402 pooled .b 2591 to 2881 293 to 3       291/293
(99 %)
0 diff
(100 %id)
BX642171   .b 2683 to 3111 1 to 424   tiling clone,   424/424
(100 %)
4 diff
(99.1 %id)
AW859072 colon .b 2695 to 2859 1 to 168       168/168
(100 %)
8 diff
(95.3 %id)
AA279176 germinal center B cell .b 2714 to 2979 466 to 201       266/471
(56 %)
0 diff
(100 %id)
GD146754   .b 2984 to 3043 5 to 64   tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 60/64
(93 %)
12 diff
(81.3 %id)
BM989280 Fibrosarcoma .b 3088 to 3531 463 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 445/445
(100 %)
2 diff
(99.6 %id)
BX483664   .b 3164 to 3731 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
BX483666   .b 3164 to 3711 1 to 548       548/548
(100 %)
7 diff
(98.8 %id)
BX483673   .b 3164 to 3711 1 to 547       547/547
(100 %)
6 diff
(99.0 %id)
CD558353 White Matter .b 3278 to 4026 1 to 761       761/926
(82 %)
28 diff
(97.0 %id)
CD519071 White Matter .b 3453 to 4302 1 to 851   tiling clone,   851/852
(99 %)
3 diff
(99.7 %id)
D63293   .b 3467 to 3838 1 to 371       371/371
(100 %)
7 diff
(98.2 %id)
AA382203   .b 3499 to 3648 1 to 150       150/150
(100 %)
0 diff
(100 %id)
BG389484 embryonal carcinoma, cell line, testis .b 3525 to 4206 1 to 674       674/674
(100 %)
15 diff
(97.8 %id)
TI_57234957   .b 3570 to 4492 64 to 991       928/991
(93 %)
6 diff
(99.4 %id)
BI908647 leukocyte .b 3571 to 4492 1 to 927       927/927
(100 %)
32 diff
(96.6 %id)
BQ945945 leiomyosarcoma, uterus .b 3639 to 4561 1 to 926   tiling clone,   926/928
(99 %)
9 diff
(99.1 %id)
AA370775 Prostate .b 3649 to 3898 1 to 250       250/250
(100 %)
0 diff
(100 %id)
FN069541 breast carcinoma .b 3890 to 3963 76 to 1     Submitted on the opposite strand 76/77
(98 %)
2 diff
(97.5 %id)
BF217902 brain, glioblastoma .b 3956 to 4561 12 to 609       598/867
(68 %)
30 diff
(96.6 %id)
CN482509 eye .b 3963 to 4553 1 to 591       591/591
(100 %)
5 diff
(99.2 %id)
AA431366.
matches multiple genes
  .b 3963 to 4463 1 to 501     also hits gene poskoy 501/501
(100 %)
2 diff
(99.7 %id)
BG530714 embryonal carcinoma, testis .b 3970 to 4593 638 to 1     Submitted on the opposite strand 638/767
(83 %)
14 diff
(98.2 %id)
BF246243 brain, glioblastoma .b 3972 to 4581 640 to 24     Submitted on the opposite strand 617/799
(77 %)
0 diff
(100 %id)
AA490423 germinal center B cell .b 3995 to 4396 11 to 412       402/412
(97 %)
6 diff
(98.6 %id)
CD707313 normal nasopharynx .b 4100 to 4382 44 to 323       280/323
(86 %)
6 diff
(98.2 %id)
AA361614   .b 4103 to 4412 1 to 310       310/310
(100 %)
3 diff
(99.1 %id)
FN174399 breast carcinoma .b 4105 to 4185 1 to 81       81/83
(97 %)
4 diff
(95.2 %id)
BG006885 placenta_normal .b 4112 to 4644 533 to 1   tiling clone,   533/533
(100 %)
4 diff
(99.3 %id)
H56121 liver and spleen .b 4118 to 4419 1 to 308       308/312
(98 %)
12 diff
(96.2 %id)
BY798135 eye .b 4119 to 4510 1 to 392       392/392
(100 %)
5 diff
(98.8 %id)
DA482487   .b 4151 to 4728 2 to 588   capped   587/587
(100 %)
9 diff
(98.5 %id)
AV715978   .b 4166 to 4913 1 to 751       751/759
(98 %)
11 diff
(98.6 %id)
CB984353 Pooled-Glandular .b 4177 to 4774 1 to 618       618/775
(79 %)
63 diff
(91.9 %id)
AA354669   .b 4199 to 4623 1 to 430       430/430
(100 %)
6 diff
(98.7 %id)
CN481913 eye .b 4242 to 4729 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
CN417883 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4390 to 5186 802 to 6     Submitted on the opposite strand 797/805
(99 %)
6 diff
(99.3 %id)
CA420024 Bone, Human Chondrosarcoma Cell Line .b 4392 to 4825 14 to 447     Submitted on the opposite strand 434/447
(97 %)
6 diff
(98.7 %id)
CN417882 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4425 to 5168 744 to 1     Submitted on the opposite strand 744/744
(100 %)
2 diff
(99.8 %id)
AA215525 germinal center B cell .b 4447 to 4903 1 to 459       459/472
(97 %)
11 diff
(97.7 %id)
AA361159   .b 4450 to 4782 1 to 334       334/334
(100 %)
2 diff
(99.5 %id)
TI_149277286   .b 4457 to 5149 793 to 91   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 703/703
(100 %)
7 diff
(99.1 %id)
BG107770 Bone, osteosarcoma, cell line .b 4462 to 5164 1 to 703   tiling clone,   703/705
(99 %)
3 diff
(99.6 %id)
AW963172   .b 4473 to 4947 1 to 476       476/487
(97 %)
32 diff
(93.5 %id)
BU677554 lung .b 4478 to 5149 700 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 682/682
(100 %)
7 diff
(99.0 %id)
CN417884 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4487 to 5162 1 to 677       677/677
(100 %)
4 diff
(99.5 %id)
TI_154024580   .b 4500 to 5182 785 to 93   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 693/694
(99 %)
7 diff
(99.0 %id)
TI_149282914   .b 4508 to 5180 759 to 81   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 679/792
(85 %)
9 diff
(98.9 %id)
TI_57180813   .b 4526 to 5182 75 to 723       649/727
(89 %)
11 diff
(98.5 %id)
BI766757 pooled lung and spleen .b 4529 to 5182 1 to 647       647/651
(99 %)
10 diff
(98.5 %id)
CA439711 lung, Metastatic Chondrosarcoma .b 4533 to 5182 676 to 17   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 660/660
(100 %)
6 diff
(99.1 %id)
BF810880 colon_ins .b 4576 to 4939 386 to 15     Submitted on the opposite strand 372/386
(96 %)
0 diff
(100 %id)
BU679968 lung, Primary Lung Epithelial Cells .b 4608 to 5180 591 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 573/573
(100 %)
2 diff
(99.7 %id)
CA425883 cell lines, Chondrosarcoma .b 4615 to 5182 584 to 17   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 568/568
(100 %)
23 diff
(96.0 %id)
BE703056 nervous_normal .b 4618 to 4911 83 to 373       291/373
(78 %)
6 diff
(98.4 %id)
BE703054 nervous_normal .b 4622 to 4982 365 to 7       359/365
(98 %)
0 diff
(100 %id)
BE703053 nervous_normal .b 4635 to 4983 368 to 16       353/368
(95 %)
0 diff
(100 %id)
AA283099 germinal center B cell .b 4652 to 5041 1 to 390   fully sequenced,   390/390
(100 %)
0 diff
(100 %id)
BM994696 lung, Metastatic Chondrosarcoma .b 4682 to 5312 650 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 632/653
(96 %)
4 diff
(99.4 %id)
N51102 multiple sclerosis lesions .b 4701 to 5182 483 to 1       483/483
(100 %)
5 diff
(99.0 %id)
BU631272 cell lines, Chondrosarcoma .b 4704 to 5312 627 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 609/609
(100 %)
1 diff
(99.9 %id)
BU632711 cell lines, Chondrosarcoma .b 4705 to 5312 626 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 608/608
(100 %)
1 diff
(99.9 %id)
AW088260 brain, tumor, 5 pooled (see description) .b 4710 to 5180 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
BE646440 B-cell, chronic lymphotic leukemia .b 4710 to 5181 476 to 5       472/476
(99 %)
0 diff
(100 %id)
AI378417 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4712 to 5182 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
AI718083 aorta .b 4717 to 5181 465 to 2       464/465
(99 %)
0 diff
(100 %id)
BQ002213 Chondrosarcoma, Left Pelvis .b 4722 to 5182 476 to 17   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 460/460
(100 %)
3 diff
(99.4 %id)
AW135410   .b 4730 to 5323 611 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 594/594
(100 %)
1 diff
(99.9 %id)
AI056595 liver and spleen .b 4744 to 5182 451 to 13   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 439/439
(100 %)
1 diff
(99.8 %id)
BP396900 pancreatic islet .b 4755 to 5179 1 to 425     Submitted on the opposite strand 425/425
(100 %)
2 diff
(99.6 %id)
AW029474 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 4766 to 5182 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
AV738434 cord Blood .b 4770 to 5180 51 to 448   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 398/448
(88 %)
7 diff
(98.5 %id)
AW384173 head_neck .b 4782 to 4904 123 to 1       123/123
(100 %)
2 diff
(98.4 %id)
BP395463 pancreatic islet .b 4802 to 4973 1 to 173     Submitted on the opposite strand 173/178
(97 %)
3 diff
(98.4 %id)
AA585483   .b 4808 to 4958 1 to 150       150/160
(93 %)
7 diff
(95.7 %id)
AW440519 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 4819 to 5182 364 to 1       364/364
(100 %)
1 diff
(99.8 %id)
AA405007 germinal center B cell .b 4826 to 5182 372 to 16   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 357/357
(100 %)
1 diff
(99.8 %id)
AI523272 aorta .b 4861 to 5182 322 to 1       322/322
(100 %)
2 diff
(99.4 %id)
AI749312 aorta .b 4861 to 5180 320 to 1       320/320
(100 %)
10 diff
(96.9 %id)
AA658346   .b 4864 to 5183 329 to 10       320/329
(97 %)
0 diff
(100 %id)
AA432363.
matches multiple genes
  .b 4875 to 5183 311 to 3     also hits gene PPP6C 309/311
(99 %)
0 diff
(100 %id)
H56045 liver and spleen .b 4918 to 5181 271 to 8       264/271
(97 %)
0 diff
(100 %id)
AA215383 germinal center B cell .b 4918 to 5312 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
AW193227 adenocarcinoma, Pancreas .b 4932 to 5313 385 to 4       382/385
(99 %)
0 diff
(100 %id)
BG254863 adenocarcinoma, cell line, Prostate .b 4940 to 5316 106 to 482   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 377/482
(78 %)
6 diff
(98.8 %id)
AI927339 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 4958 to 5312 374 to 20   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 355/355
(100 %)
5 diff
(98.6 %id)
FN154279 breast carcinoma .b 4998 to 5092 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
AA283012 germinal center B cell .b 5011 to 5182 172 to 1   fully sequenced,   172/172
(100 %)
1 diff
(99.5 %id)
FN123611 breast carcinoma .b 5023 to 5124 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
AA872988 germinal center B cell .b 5051 to 5300 250 to 1       250/250
(100 %)
2 diff
(99.2 %id)
BQ015020 Chondrosarcoma, Left Pubic Bone .b 5085 to 5312 246 to 19   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 228/228
(100 %)
1 diff
(99.6 %id)
AA687330 germinal center B cell .b 5114 to 5312 226 to 28   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 199/199
(100 %)
2 diff
(99.0 %id)
BP283863 bone marrow .c-u 1 to 592 1 to 592   tiling clone,   592/592
(100 %)
4 diff
(99.4 %id)
DA675850   .c-u 71 to 647 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA677261   .c-u 71 to 569 2 to 500   capped   499/499
(100 %)
4 diff
(99.2 %id)
DA938746 Spleen .c-u 71 to 608 2 to 541   capped   540/540
(100 %)
4 diff
(99.3 %id)
BC052561 Spleen .c-u 109 to 2553 1 to 2442 L92F tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 2442/2442
(100 %)
6 diff
(99.8 %id)
DB140207 thymus .c-u 164 to 596 2 to 435   capped   434/434
(100 %)
3 diff
(99.4 %id)
CR999430 T-Lymphocytes .c-u 182 to 590 1 to 409   tiling clone,   409/409
(100 %)
0 diff
(100 %id)
AW971693   .c-u 981 to 1481 501 to 1     Submitted on the opposite strand 501/501
(100 %)
9 diff
(98.3 %id)
AW070323 pooled .c-u 1039 to 1465 453 to 27   AAA   427/435
(98 %)
13 diff
(97.1 %id)
AA740907 germinal center B cell .c-u 1153 to 1480 344 to 17   tiling clone, AAA   328/328
(100 %)
0 diff
(100 %id)
AA258138 germinal center B cell .c-u 1269 to 1482 214 to 1       214/214
(100 %)
0 diff
(100 %id)
AA585286   .c-u 1291 to 1480 183 to 1       183/195
(93 %)
8 diff
(95.9 %id)
DA992244 synovial membrane tissue from rheumatioidarthritis .d 1 to 506 2 to 508   tiling clone, capped   507/507
(100 %)
2 diff
(99.7 %id)
CD700979 normal nasopharynx .d 640 to 1224 25 to 609   tiling clone,   585/609
(96 %)
6 diff
(99.1 %id)
AV764525 bone marrow .d 1028 to 1054 589 to 614   tiling clone,   594/616
(96 %)
15 diff
(97.6 %id)
DR423754 eye, Pterygium .e-u 1 to 831 8 to 838 exact tiling clone,   831/838
(99 %)
6 diff
(99.3 %id)
DR421823 eye, Pterygium .e-u 65 to 454 1 to 392       392/392
(100 %)
8 diff
(98.0 %id)
CD705936 normal nasopharynx .e-u 784 to 1207 31 to 455   tiling clone,   425/455
(93 %)
6 diff
(98.7 %id)
BX477042   .f-u 1 to 688 1 to 688 exact tiling clone,   688/688
(100 %)
4 diff
(99.5 %id)
DB032907 testis .g 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
GD153872   .g 212 to 306 1 to 95       95/96
(98 %)
7 diff
(92.8 %id)
GD153971   .g 212 to 306 1 to 95       95/96
(98 %)
7 diff
(92.8 %id)
DB134766 thymus .h-u 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
AW269656 pooled .i-u 1 to 422 428 to 2 exact tiling clone,   427/428
(99 %)
0 diff
(100 %id)
AI284424 lymph node, mantle cell lymphoma .i-u 85 to 435 356 to 1   tiling clone,   356/356
(100 %)
3 diff
(99.2 %id)
AU253043 neuroblastoma Gene STK17B, variant not shown         This clone was ignored    
AU253042 neuroblastoma Gene STK17B, variant not shown         This clone was ignored    
AV747780 Pituitary Gene STK17B, variant not shown         Suspected internal deletion, this clone was ignored    
DB015488 esophageal, tumor tissue Gene STK17B, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB335451 esophageal, tumor tissue Gene STK17B, variant not shown         Suspected internal deletion, this clone was ignored    
DB111654 thymus Gene STK17B, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB343369 thymus Gene STK17B, variant not shown         Suspected internal deletion, this clone was ignored    
CD695486 normal nasopharynx Gene STK17B, variant not shown         Suspected internal deletion, this clone was ignored    
CV329779 uterus_tumor Gene STK17B, variant not shown              
AW862909 stomach_normal Gene STK17B, variant not shown              
AA714506 germinal center B-cells, tonsil Gene STK17B, variant not shown         This clone was ignored    
AI632647 pooled germ cell tumors Gene STK17B, variant not shown         This clone was ignored    
AI990894 pooled germ cell tumors Gene STK17B, variant not shown         This clone was ignored    
BF509995   Gene STK17B, variant not shown       AAA This clone was ignored    
BF062019 pooled germ cell tumors Gene STK17B, variant not shown         This clone was ignored    
DB151946 thymus Gene STK17B, variant not shown       capped      
DB346198 thymus Gene STK17B, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e-u, .f-u, .g, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI